ArticlePloS one2023

Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer's disease with cerebrovascular disease.

Diana Karamacoska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.